Contineum Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2022 | — | $-93.2M | — |
| Mar 2023 | — | $-97.5M | — |
| Jun 2023 | — | $-55.4M | — |
| Sep 2023 | — | $-61.1M | — |
| Dec 2023 | — | $-67.9M | $15.5M |
| Mar 2024 | — | $-75.6M | $16.3M |
| Jun 2024 | — | $217.5M | $77.2M |
| Sep 2024 | — | $210.2M | $40.9M |
| Dec 2024 | — | $198.1M | $21.9M |
| Mar 2025 | — | $184.8M | $22.5M |
| Jun 2025 | — | $171.4M | $20.8M |
| Sep 2025 | — | $180.5M | $42.6M |
| Dec 2025 | — | $261.0M | $75.6M |
| Mar 2026 | — | $250.0M | $20.2M |
| Jun 2026 | — | $239.7M | $14.7M |